DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
McMurray J, Ostergren J, Swedberg K. et al.
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial.
Lancet 2003;
362: 767-771 doi:10.1016/S0140-6736(03)14283-3
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.